Chromosome 17 Copy Predicts Response to Anthracyclines (Doxorubicin)
After much debate at breast tumor boards throughout the world on the importance of HER2 and topoisomerase II (an enzyme involved in DNA replication) in predicting response to Anthracyclines, it seems that an extra copy of chromosome 17 in the cancer may be predictive. Things change pretty quickly. We typically don't analyze chromosome 17... Read more
